We serve today’s and tomorrow’s market needs by bringing biotech and specialty chemical expertise to our customers.
With more than a century of experience, we have a unique capability to connect biotech expertise with fine chemical know-how, which allows us to provide the best solutions for our customers’ success.
By continuously developing our technologies, we enable our customers to meet some of the world’s greatest challenges such as the vital need for disease prevention and treatment, clean water, abundant food, advanced materials, and enhanced hygiene and wellness.
Around the world we are driven by our firm commitment to high quality and operational excellence across the regions, functions and markets we serve, every day.
Empowerment, trust and integrity govern how we do business and how we interact with each other. As individuals and as teams, we are making this the place to go, stay and grow.
We are Lonza.
180 articles with Lonza
Lonza and Innosieve Diagnostics Announce Exclusive Distribution Agreement for Rapid Bioburden Testing Technology
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology.
Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.
Lonza to Host New Webinar: “CRISPR – Tips and Tricks for Efficient Delivery into Primary Cells and Cell Lines”
Lonza is hosting a free 60-minute webinar on the CRISPR/Cas9 genome editing method.
Proteon Therapeutics, Inc. announced a long-term contract extension with Lonza Pharma & Biotech for the commercial supply of investigational vonapanitase’s active pharmaceutical ingredient (API).
Synpromics awarded Innovate UK grant to evaluate its inducible promoter platform in collaboration with Lonza Pharma & Biotech
Synpromics Ltd announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals.
Lonza Opens World's Largest Dedicated Cell and-Gene-Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases
Lonza will establish Centers of Excellence for Cell and Gene Therapy to support and accelerate the growth of this priority area for the company.
This new product offering from Lonza is a result of a worldwide marketing and distribution agreement with Kirkstall.
Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines
The agreement covers all stages of the development and manufacturing.
Lonza to Present Latest Research into More Physiologically Relevant ADME-Tox Models at the Society of Toxicology Meeting
With studies suggesting primary hepatocytes can quickly lose many of their in vivo functions when cultured as a monolayer.
Lonza Reports Record-Breaking Full-Year Results With Double-Digit Lonza Standalone Sales Growth and More than 26% CORE EBIT Growth in a Major Transformational Year
Lonza today announced its record-breaking 2017 full-year results, which included double-digit organic sales growth, organic CORE EBITDA and CORE EBIT growth well above sales growth and an attractive CORE RONOA of 28.3% for Lonza standalone.
At Booth 534 Lonza will showcase how its automated QC testing solutions and Nucleofector Devices can increase efficiency and throughput in the drug development process.
Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders
The agreement with Akouos is designed to accelerate AAV gene therapy for hearing and balance disorder.
In the third quarter of 2017, Lonza reported continued strong performance and therefore confirms its full-year 2017 guidance on a standalone basis, which was already upgraded with Q1 2017 Qualitative Business Update in April 2017.
Lonza's MODA-EM Version 3.3 software enables microbiology Quality Control (QC) laboratories to comply with new regulatory guidelines.
Lonza Group To Host New Webinar: “Challenges And Strategies For Paperless Product Release – Bringing The Pieces Together”